On the use of corticosteroids for 2019-nCoV pneumonia

doi:10.1016/S0140-6736(20)30361-5

Comment

. 2020 Feb 29;395(10225):683-684.

doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang¹, Jianping Zhao², Yi Hu³, Ronghui Du⁴, Bin Cao⁵

Affiliations

¹ Beijing University of Chinese Medicine, Beijing, China; Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
² Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China.
⁴ Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China.
⁵ Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

PMID: 32122468
PMCID: PMC7159292
DOI: 10.1016/S0140-6736(20)30361-5

Comment

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang et al. Lancet. 2020.

. 2020 Feb 29;395(10225):683-684.

doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.

Authors

Lianhan Shang¹, Jianping Zhao², Yi Hu³, Ronghui Du⁴, Bin Cao⁵

Affiliations

¹ Beijing University of Chinese Medicine, Beijing, China; Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China.
² Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
³ Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Wuhan, China.
⁴ Department of Pulmonary and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan, China.
⁵ Department of Pulmonary and Critical Care Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

PMID: 32122468
PMCID: PMC7159292
DOI: 10.1016/S0140-6736(20)30361-5

No abstract available

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Comment in

Contrasting evidence for corticosteroid treatment for coronavirus-induced cytokine storm.
Leung KKY, Hon KL, Qian SY, Cheng FWT. Leung KKY, et al. Hong Kong Med J. 2020 Jun;26(3):269-271. doi: 10.12809/hkmj208517. Epub 2020 Jun 5. Hong Kong Med J. 2020. PMID: 32536610 No abstract available.

Comment on

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
Russell CD, Millar JE, Baillie JK. Russell CD, et al. Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7. Lancet. 2020. PMID: 32043983 Free PMC article. No abstract available.

Cited by

Effect of methylprednisolone in reducing severe COVID-19 and mortality in high-risk patients: A retrospective study.
Xiao Y, Wang J, Yang K, Jiang M, Luo J, Chen K, Zhang B. Xiao Y, et al. SAGE Open Med. 2024 Sep 9;12:20503121241276683. doi: 10.1177/20503121241276683. eCollection 2024. SAGE Open Med. 2024. PMID: 39257516 Free PMC article. Review.
Clinical characteristics, treatment and prognosis of children with SARS-CoV-2 infection complicated with severe neurological dysfunctions in Foshan, China.
Chen X, Liang Y, Jiang S. Chen X, et al. Front Pediatr. 2024 Aug 16;12:1414023. doi: 10.3389/fped.2024.1414023. eCollection 2024. Front Pediatr. 2024. PMID: 39220151 Free PMC article.
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
Mia ME, Howlader M, Akter F, Hossain MM. Mia ME, et al. Clin Pathol. 2024 Jul 26;17:2632010X241263054. doi: 10.1177/2632010X241263054. eCollection 2024 Jan-Dec. Clin Pathol. 2024. PMID: 39070952 Free PMC article. Review.
B cells modulate lung antiviral inflammatory responses via the neurotransmitter acetylcholine.
Baumgarth N, Prieto AC, Luo Z, Kulaga H. Baumgarth N, et al. Res Sq [Preprint]. 2024 Jun 25:rs.3.rs-4421566. doi: 10.21203/rs.3.rs-4421566/v1. Res Sq. 2024. PMID: 38978583 Free PMC article. Preprint.
Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before-After Study (CortiCOVID Study).
Espinosa-Solano M, Gonzalez-Vergara D, Ferrer-Galvan M, Asensio-Cruz MI, Lomas JM, Roca-Oporto C, Navarro-Amuedo MD, Paniagua-Garcia M, Sotomayor C, Espinosa N, Garcia-Gutierrez M, Molina Gil-Bermejo J, Aguilar-Guisado M, Poyato M, Praena-Segovia J, Palomo A, Borrero-Rodriguez M, Cordero E, Caballero-Eraso C, Jara-Palomares L; CortiCOVID-19 Team. Espinosa-Solano M, et al. Open Respir Arch. 2021 Mar 19;3(2):100086. doi: 10.1016/j.opresp.2021.100086. eCollection 2021 Apr-Jun. Open Respir Arch. 2021. PMID: 38620829 Free PMC article.

See all "Cited by" articles

References

1. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 doi: 10.1016/S0140-6736(20)30317-2. published online Feb 7. - DOI - PMC - PubMed
1. WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-ac...
1. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed
1. Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452. - PMC - PubMed
1. Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345–354. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations
Medical
- MedlinePlus Health Information

[1] Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 doi: 10.1016/S0140-6736(20)30317-2. published online Feb 7. - DOI - PMC - PubMed

[2] Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 doi: 10.1016/S0140-6736(20)30317-2. published online Feb 7. - DOI - PMC - PubMed

[3] WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-ac...

[4] WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-ac...

[5] Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed

[6] Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed

[7] Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452. - PMC - PubMed

[8] Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452. - PMC - PubMed

[9] Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345–354. - PMC - PubMed

[10] Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345–354. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

On the use of corticosteroids for 2019-nCoV pneumonia

Affiliations

On the use of corticosteroids for 2019-nCoV pneumonia

Authors

Affiliations

Figures

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical